Riskpilot← Back to searchSign inGet full accessValidicity Sweden AB
ABActiveOrg 5591489496Skagens Fyrs Väg 1 ADiagnostic imaging services and medical laboratory activities · NACE 8691Est. 20180 employees
Revenue 2024
SEK 0
EBITDA margin
—
+65% vs 2023
Equity ratio
35.2%
Financial strength
Net profit 2024
SEK -11K
+65% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -11K | +65% |
| Net profit | SEK -11K | +65% |
| Total assets | SEK 713K | +14% |
| Equity | SEK 251K | +55% |
| Employees | 0 | — |
Legal name
Validicity Sweden AB
Org number
5591489496
Legal form
Aktiebolag
NACE code
8691 · Diagnostic imaging services and medical laboratory activities
Founded
12 februari 2018
Share capital
SEK 52 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva utveckling av säkert provtagningsmaterial för doping, drog och medicinska tester och därmed förenlig verksamhet.
Address
Skagens Fyrs Väg 1 A
Email
debbie@lygonis.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −54 | −146 | −76 | −31 | −11 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −54 | −146 | −76 | −31 | −11 |
| Net financials | — | — | — | — | — |
| Profit before tax | −54 | −146 | −76 | −31 | −11 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −54 | −146 | −76 | −31 | −11 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 877 | 728 | 652 | 626 | 713 |
| Equity | 414 | 268 | 192 | 162 | 251 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 463 | 460 | 460 | 465 | 462 |
| Total debt | 463 | 460 | 460 | 465 | 462 |
EBITDA margin
-1100000.0%
This company
15.8%
Market median
-6962125% vs market
20202024
Equity ratio
35.2%
This company
38.2%
Market median
+8% vs market
20202024
Return on equity
-4.4%
This company
18.4%
Market median
-124% vs market
20202024
Net profit margin
-1100000.0%
This company
8.1%
Market median
-13580347% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
1.84×
This company
0.62×
Market median
-197% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
KE Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2020 | |
| Board of Directors | 2020 | |
| Chairman | 2020 | |
| Former (1) | ||
| Board of Directors | 2020 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Validicity Sweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karin Erika Grute Movin | Chief Executive Officer | 0 companies |
| Sven Staffan Andreas Movin | Board of Directors | 0 companies |
| Spiridon Constantine Donnie Lygonis | Deputy Board Member | 0 companies |
| Leif Rune Staffan Sahlström | Board of Directors | 0 companies |
| Deborah Helen May Lygonis | Chairman | 0 companies |